A Cross-sectional REVEAL Sub-study Evaluating the Effect of Anacetrapib on Vascular Function and Arterial Stiffness [An Investigator Led Sub-study of HPS3/TIMI 55: REVEAL]
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Anacetrapib (Primary) ; Atorvastatin
- Indications Cardiovascular disorders; Vascular disorders
- Focus Therapeutic Use
- Acronyms REVEAL-Vasc
- 23 Jun 2017 Planned number of patients changed from 90 to 130.
- 10 Jan 2017 Status changed from not yet recruiting to recruiting.
- 19 Oct 2016 New trial record